Review
doi: 10.1055/s-2005-871993.
Bronchioloalveolar carcinoma: a review of the epidemiology, pathology, and treatment
Affiliations
- PMID: 16052436
- DOI: 10.1055/s-2005-871993
Item in Clipboard
Review
Bronchioloalveolar carcinoma: a review of the epidemiology, pathology, and treatment
Semin Respir Crit Care Med.
2005 Jun.
Abstract
Bronchioloalveolar carcinoma (BAC) is an important subtype of pulmonary adenocarcinoma. It has received increasing attention in recent years, due to its increasing incidence and its rate of sensitivity to epidermal growth factor-tyrosine kinase inhibitors (EGFR-TKIs). This article reviews the epidemiology, risk factors, pathology, clinical presentation, and treatment of this disease. Special focus is paid to the emerging role of oral EGFR-TKIs in Bronchioloalveolar cell carcinoma.
Similar articles
-
Cytomorphological correlates of epidermal growth factor receptor mutations in lung carcinoma.Diagn Cytopathol. 2007 May;35(5):257-62. doi: 10.1002/dc.20617. Diagn Cytopathol. 2007. PMID: 17427221
-
[Other thoracic cancers. Bronchioloalveolar carcinoma and adenocarcinoma with bronchioloalveolar carcinoma feature: a clinico-pathological spectrum].Rev Mal Respir. 2008 Oct;25(8 Pt 2):3S196-202. Rev Mal Respir. 2008. PMID: 18971846 French.
-
Epidermal growth factor receptor signaling in adenocarcinomas with bronchioloalveolar components.Ann Thorac Surg. 2008 Jan;85(1):216-23. doi: 10.1016/j.athoracsur.2007.07.046. Ann Thorac Surg. 2008. PMID: 18154814
-
[Clinical types of thoracic cancer. Bronchiolo-alveolar carcinoma and adenocarcinoma with bronchioloalveolar features: a clinico-pathological spectrum].Rev Mal Respir. 2006 Nov;23(5 Pt 3):16S158-16S163. Rev Mal Respir. 2006. PMID: 17268353 Review. French.
-
[Bronchioloalveolar carcinoma and adenocarcinoma with bronchioloalveolar features: a clinico-pathological spectrum].Rev Mal Respir. 2007 Oct;24(8 Pt 2):6S165-70. Rev Mal Respir. 2007. PMID: 18235410 Review. French.
Cited by
-
Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population.Clin Cancer Res. 2009 Aug 15;15(16):5216-23. doi: 10.1158/1078-0432.CCR-09-0802. Epub 2009 Aug 11. Clin Cancer Res. 2009. PMID: 19671850 Free PMC article.
-
The EGFR family members sustain the neoplastic phenotype of ALK+ lung adenocarcinoma via EGR1.Oncogenesis. 2013 Apr 8;2(4):e43. doi: 10.1038/oncsis.2013.7. Oncogenesis. 2013. PMID: 23567620 Free PMC article.
-
Aberrant Signaling through the HER2-ERK1/2 Pathway is Predictive of Reduced Disease-Free and Overall Survival in Early Stage Non-Small Cell Lung Cancer (NSCLC) Patients.J Cancer. 2017 Jan 15;8(2):227-239. doi: 10.7150/jca.17093. eCollection 2017. J Cancer. 2017. PMID: 28243327 Free PMC article.
-
The 2011 IASLC/ATS/ERS pulmonary adenocarcinoma classification: a landmark in personalized medicine for lung cancer management.J Thorac Dis. 2014 Oct;6(Suppl 5):S589-96. doi: 10.3978/j.issn.2072-1439.2014.09.15. J Thorac Dis. 2014. PMID: 25349710 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
